Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia

This publication has 38 references indexed in Scilit:

• Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart Disease
  The American Journal of Cardiology, 2008
• Omega-3 fatty acids and cardiovascular disease: A case for omega-3 index as a new risk factor
  Pharmacological Research, 2007
• Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study)
  The American Journal of Cardiology, 2007
• Non–High-Density Lipoprotein and Very-Low-Density Lipoprotein Cholesterol and Their Risk Predictive Values in Coronary Heart Disease
  The American Journal of Cardiology, 2006
• Dietary Omega-3 Fatty Acid Intake and Cardiovascular Risk
  The American Journal of Cardiology, 2006
• Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II
  American Heart Journal, 2006
• Secondary Prevention of Coronary Artery Disease with Omega-3 Fatty Acids
  The American Journal of Cardiology, 2006
• Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations
  The American Journal of Cardiology, 2005
• Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
  The American Journal of Cardiology, 2005
• Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin
  The American Journal of Cardiology, 2005